Product Information
METFORMIN HCL ER 750 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0545 per EA under NDC 33342024011. Its NADAC has been published 388 times since Dec 13, 2017.
FDA first approved this application on Dec 7, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342024011
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206955FDA Approved
12/7/2016
TE Code
AB1
On Market Since
12/8/2016
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 388 times since Dec 13, 2017, and over the history we have for it it has declined 27.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0545 per EA |
|---|---|
| All-time high | $0.0942 (Feb 10, 2021) |
| All-time low | $0.0545 (Apr 23, 2025) |
| Median price | $0.0668 |
| Average price | $0.0697 |
| Largest weekly change | +26.5% (Dec 23, 2020) |
| Weeks tracked | 388 |
| Tracking since | Dec 13, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-17.0%
5Y
-38.8%
All
-27.5%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0545 per EA (NDC 33342024011), effective May 14, 2025.
How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 27.5%. It has been tracked across 388 weekly CMS publications since Dec 13, 2017.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?
Since Dec 13, 2017, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0545 (Apr 23, 2025) to a high of $0.0942 (Feb 10, 2021), with a median of $0.0668 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL ER 750 MG TABLET, is $0.0542 per EA — about 1% below METFORMIN HCL ER 750 MG TABLET.
Who manufactures METFORMIN HCL ER 750 MG TABLET?
METFORMIN HCL ER 750 MG TABLET (NDC 33342024011) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.